Current Gel Electrophoresis Approaches to Low-Abundance Protein Marker Discovery - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 183

12. Cong WT, Hwang SY, Jin LT, et al. Sensitive uorescent

staining for proteomic analysis of proteins in 1-D and
2-D SDS-PAGE and its comparison with SYPRO Ruby
by PMF. Electrophoresis 2008; 29 :4304 e 15.
13. Lilley KS, Friedman DB. All about DIGE: quanti

26. Xu Y, Wang BC, Zhu YX. Identi cation of proteins

expressed at extremely low level in Arabidopsis leaves.
Biochem Biophys Res Commun 2007; 358 :808 e 12.
27. Echan LA, Tang HY, Ali-Khan N, et al. Depletion of
multiple high-abundance proteins improves protein
pro

cation
technology for differential-display 2D-gel proteomics.
Expert Rev. Proteomics 2004; 1 :401 e 9.
14. Unlu M, Morgan ME, Minden JS. Difference gel elec-
trophoresis: a single gel method for detecting changes
in protein extracts. Electrophoresis 1997; 18 :2071 e 7.
15. Alban A, David SO, Bjorkesten L, et al. A novel
experimental design for comparative two-dimensional
gel analysis: two-dimensional difference gel electro-
phoresis incorporating a pooled internal standard.
Proteomics 2003; 3 :36 e 44.
16. Westbrook JA, Yan JX, Wait R, et al. Zooming-in on the
proteome: very narrow-range immobilised pH gradi-
ents reveal more protein species and isoforms. Electro-
phoresis 2001; 22 :2865 e 71.
17. Tirumalai RS, Chan KC, Prieto DA, et al. Character-
ization of the low molecular weight human serum
proteome. Mol Cell Proteomics 2003; 2 :1096 e 103.
18. Fountoulakis Takacs MF, Takacs B. Enrichment of
low-copy-number gene products by hydrophobic
interaction chromatography. J Chromatogr A 1999; 833 :
57 e 168.
19. Dayarathna MK, Hancock WS, Hincapie M. A two
steps fractionation approach for plasma proteomics
using immunodepletion of abundant proteins and
multi-lectin af

ling capacities of human serum and plasma. Pro-
teomics 2005; 5 :3292 e 303.
28. Hinerfeld D, Innamorati D, Pirro J, et al. Serum/Plasma
depletion with chicken immunoglobulin Y antibodies
for proteomic analysis from multiple mammalian
species. J Biomol Tech 2004; 15 :184 e 90.
29. Lin B, White JT, Wu J, et al. Deep depletion of abundant
serum proteins reveals low-abundant proteins as
potential biomarkers for human ovarian cancer. Pro-
teomics Clin Appl 2009; 3 :853 e 61.
30. Stempfer R, Kubicek M, Lang IM, et al. Quantitative
assessment of human serum high-abundance protein
depletion. Electrophoresis 2008; 29 :4316 e 23.
31. Shen Y, Kim J, Strittmatter EF, et al. Characterization of
the human blood plasma proteome. Proteomics 2005; 5 :
4034 e 45.
32. Yadav AK, Bhardwaj G, Basak T, et al. A systematic
analysis of eluted fraction of plasma post immu-

noaf nity depletion: implications in biomarker

discovery. PLoS ONE 2011; 6 :e24442.
33. Tu C, Rudnick PA, Martinez MY, et al. Depletion of
abundant plasma proteins and limitations of plasma
proteomics. J. Proteome Res 2010; 9 :4982 e 91.
34. Afkarian M, Bhasin M, Dillon ST, et al. Optimizing
a proteomics platform for urine biomarker discovery.
Mol Cell Proteomics 2010; 9 :2195 e 204.
35. Righetti PG, Boschetti E. The art of observing rare
protein species with peptide libraries. Proteomics 2009; 9 :
1492 e 510.
36. Righetti PG, Boschetti E, Kravchuk A, et al. The pro-
teome buccaneers: how to unearth your treasure chest
via combinatorial peptide ligand libraries. Exp Rev
Proteomics 2010; 7 :373 e 85.
37. Li L, Sun CJ, Freeby S, Yee D, et al. Protein sample
treatment with peptide ligand library: coverage and
consistency. J Prot Bioinform 2009; 2 :485 e 94.
38. Mouton-Barbosa E, Roux-Dalvai F, Bouyssié D, et al.
In-depth

nity chromatography: Application to
the analysis of obesity, diabetes and hypertension
diseases. J Sep Sci 200;831:1156 e 66.
20. Lei T, He QY, Wang YL, et al. Heparin chromatography
to deplete high-abundance proteins for serum proteo-
mics. Clin Chim Acta 2008; 388 :173 e 8.
21. Andersen JN, Sathyanarayanan S, Di Bacco A, et al.
Pathway-based identi cation of biomarkers for tar-

geted therapeutics: personalized oncology with PI3K
pathway inhibitors. Sci Transl Med 2010; 2 :43 e 55.
22. Sykora C, Hoffmann R, Hoffmann P. Enrichment of
multiphosphorylated peptides by immobilized metal
af nity chromatography using Ga(III)- and Fe(III)-

complexes. Protein Pept Lett 2007; 14 :489 e 96.
23. Thingholm TE, Jørgensen TJ, Jensen ON, et al. Highly
selective enrichment of phosphorylated peptides using
titanium dioxide. Nat Protoc 2006; 1 :1929 e 35.
24. Shi Q, Gibson GE. Oxidative stress and transcriptional
regulation in Alzheimer disease. Alzheimer Dis Assoc
Disord 2007; 21 :276 e 91.
25. Ni RJ, Shen Z, Yang CP, et al. Identi

fluid by
combining peptide ligand library treatment and label-
free protein quanti

exploration of cerebrospinal

cation. Mol Cell Proteomics 2010; 9 :

1006 e 21.
39. Zhi W, Purohit S, Carey C, et al. Proteomic technologies
for the discovery of type 1 diabetes biomarkers. J Dia-
betes Sci Technol 2010; 4 :993 e 1002.
40. Matos JM, Witzmann FA, Cummings OW, et al. A pilot
study of proteomic pro

cation of low

abundance polyA-binding proteins in Arabidopsis les of human hepatocellular

carcinoma in the United States. J Surg Res 2009; 155 :
237 e 43.

chloroplast using polyA-af nity column. Mol Biol Rep

2010; 37 :637 e 41.